Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Objective: We investigated the occurrence and characteristics of secondary solid cancers (SSCs) in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (Ph- MPNs) from Türkiye. We identified the potential risk factors for SSC development, including the impact of cytoreductive...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy, Aynur Daglar Aday, Emine Gültürk, Meliha Nalçacı, İpek Yönal Hindilerden
Format:	Article
Language:	English
Published:	Galenos Publishing House 2024-12-01
Series:	Turkish Journal of Hematology
Subjects:	philadelphia chromosome-negative myeloproliferative neoplasm secondary solid cancers cytoreductive treatment interferon
Online Access:	https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-63549
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Lisa Pieri, et al.
Published: (2010-06-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
by: Yoko Edahiro, et al.
Published: (2024-12-01)

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria
by: Mohamed A. Yassin, et al.
Published: (2020-07-01)

Novel additional cytogenetic abnormalities associated with Philadelphia chromosome
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01)

Enhanced Platelet Activity May Increase The Risk of Myocardial Infarction and Stroke in Patients with Chronic Myeloproliferative Neoplasms
by: Viola Maria Popov, et al.
Published: (2014-08-01)

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01)

Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms
by: Joshua W. Bliss, et al.
Published: (2024-12-01)

The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review
by: Mostafa Najim, et al.
Published: (2024-12-01)

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference
by: Nikolayenko-Kamyshova T.P.
Published: (2015-09-01)

Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASM (PRIMARY MYELOFIBROSIS) – AS ONE OF THE REASONS OF THE BUDD-CHIARI SYNDROME. CLINICAL CASE OF A YOUNG PATIENT.
by: Manana Alexandrovna Sokolova, et al.
Published: (2014-08-01)

Regulation of STAT5 phosphorylation and interaction with SHP1 by lnc-AC004893, a long non-coding RNA overexpressed in myeloproliferative neoplasms
by: Junjun Yang, et al.
Published: (2024-12-01)

MAP-ping Queerness? Street Art in Philadelphia
by: Lara Cox
Published: (2023-11-01)

A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
by: Mert Erciyestepe, et al.
Published: (2020-01-01)

THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION
by: Emmanouil Spanoudakis, et al.
Published: (2018-10-01)

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference.
by: T. P. Nikolayenko-Kamyshova
Published: (2015-09-01)

PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
by: Orietta Spinelli, et al.
Published: (2014-08-01)

Severe autoimmune hemolytic anemia in Covid-19 infection
by: Fehmi Hindilerden, et al.
Published: (2020-06-01)

Propriedades Psicométricas da Philadelphia Mindfulness Scale considerando fumadores e não fumadores portugueses
by: Hugo Rodrigues-Fernandes, et al.
Published: (2021-09-01)

Where Is My Country?: From Everyday Life to the Emigration Complex in Brian Friel’s Philadelphia, Here I Come!
by: Hawk Chang
Published: (2024-12-01)

Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker
by: Fadul A, et al.
Published: (2024-12-01)

Prevalence and clinicopathological features of driver gene mutations profile in BCR:ABL1 negative classical myeloproliferative neoplasm—A single-center study from North India
by: Khaliqur Rahman, et al.
Published: (2024-12-01)

A young adult patient with Philadelphia positive acute lymphoblastic leukemia presenting with extreme hyperleukocytosis
by: Gulten Tikit, et al.
Published: (2025-01-01)

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
by: Stine Ulrik Mikkelsen, et al.
Published: (2018-08-01)

Clinical efficacy and safety of flumatinib versus dasatinib combined with multi-drug chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia
by: Qian Liu, et al.
Published: (2024-12-01)

Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest
by: Julie Mondet, et al.
Published: (2015-01-01)

Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients
by: Christopher Puli'uvea, et al.
Published: (2024-12-01)

Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDER (IDIOPATHIC MYELOFIBROSIS) – AS ONE OF THE REASONS OF THE BUDD-CHIARI SYNDROME. CLINICAL CASE OF A YOUNG PATIENT
by: Maria Dmitrievna Sanatko
Published: (2014-08-01)

A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens
by: Zhen-Yu Xiong, et al.
Published: (2024-12-01)

An interesting case of chronic myeloid leukemia with twists and turns
by: Thulasi Raman Ramalingam, et al.
Published: (2024-12-01)

Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024-09-01)

A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features
by: Jason Koshy, et al.
Published: (2013-01-01)

Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib
by: Takayoshi Tachibana, et al.
Published: (2024-12-01)

Analysis of cerebrospinal fluid chimerism after hematopoietic stem cell transplantation: Case report
by: Yeliz Ogret, et al.
Published: (2024-12-01)

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients
by: Jeffrey Baron, et al.
Published: (2024-01-01)

Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver
by: Alessandro Malara, et al.
Published: (2018-11-01)

The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015-01-01)

Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Samantha M. Ruff, et al.
Published: (2025-01-01)

Promising Findings in Myeloproliferative Neoplasms and AL Amyloidosis
by: Axel Rüfer
Published: (2022-10-01)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
by: Patrycja Zielinska, et al.
Published: (2014-01-01)